Billy R. Martin - Publications

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Behavioral Pharmacology of Cannabinoids

269 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Wiley JL, Smith VJ, Chen J, Martin BR, Huffman JW. Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents. Bioorganic & Medicinal Chemistry. 20: 2067-81. PMID 22341572 DOI: 10.1016/J.Bmc.2012.01.038  0.609
2012 Wiley JL, Marusich JA, Martin BR, Huffman JW. 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice. Drug and Alcohol Dependence. 123: 148-53. PMID 22127210 DOI: 10.1016/J.Drugalcdep.2011.11.001  0.583
2011 Wiley JL, Breivogel CS, Mahadevan A, Pertwee RG, Cascio MG, Bolognini D, Huffman JW, Walentiny DM, Vann RE, Razdan RK, Martin BR. Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist. European Journal of Pharmacology. 651: 96-105. PMID 21114999 DOI: 10.1016/J.Ejphar.2010.10.085  0.814
2010 Huffman JW, Hepburn SA, Lyutenko N, Thompson AL, Wiley JL, Selley DE, Martin BR. 1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor. Bioorganic & Medicinal Chemistry. 18: 7809-15. PMID 20943404 DOI: 10.1016/J.Bmc.2010.09.061  0.592
2010 Huffman JW, Hepburn SA, Reggio PH, Hurst DP, Wiley JL, Martin BR. Synthesis and pharmacology of 1-methoxy analogs of CP-47,497. Bioorganic & Medicinal Chemistry. 18: 5475-82. PMID 20621488 DOI: 10.1016/J.Bmc.2010.06.054  0.604
2010 Carroll FI, Ma W, Deng L, Navarro HA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists. Journal of Natural Products. 73: 306-12. PMID 20038125 DOI: 10.1021/Np9006124  0.398
2009 Vann RE, Warner JA, Bushell K, Huffman JW, Martin BR, Wiley JL. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. European Journal of Pharmacology. 615: 102-7. PMID 19470387 DOI: 10.1016/J.Ejphar.2009.05.010  0.585
2008 Merritt LL, Martin BR, Walters C, Lichtman AH, Damaj MI. The endogenous cannabinoid system modulates nicotine reward and dependence. The Journal of Pharmacology and Experimental Therapeutics. 326: 483-92. PMID 18451315 DOI: 10.1124/Jpet.108.138321  0.671
2008 Vann RE, Gamage TF, Warner JA, Marshall EM, Taylor NL, Martin BR, Wiley JL. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Drug and Alcohol Dependence. 94: 191-8. PMID 18206320 DOI: 10.1016/J.Drugalcdep.2007.11.017  0.78
2008 McKinney DL, Cassidy MP, Collier LM, Martin BR, Wiley JL, Selley DE, Sim-Selley LJ. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 324: 664-73. PMID 17967938 DOI: 10.1124/Jpet.107.130328  0.635
2008 Ivy Carroll F, Yokota Y, Ma W, Lee JR, Brieaddy LE, Burgess JP, Navarro HA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs. Bioorganic & Medicinal Chemistry. 16: 746-54. PMID 17964169 DOI: 10.1016/J.Bmc.2007.10.027  0.397
2008 Huffman JW, Thompson AL, Wiley JL, Martin BR. Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940. Bioorganic & Medicinal Chemistry. 16: 322-35. PMID 17919913 DOI: 10.1016/J.Bmc.2007.09.033  0.602
2007 Carroll FI, Robinson TP, Brieaddy LE, Atkinson RN, Mascarella SW, Damaj MI, Martin BR, Navarro HA. Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine. Journal of Medicinal Chemistry. 50: 6383-91. PMID 17994682 DOI: 10.1021/Jm0704696  0.339
2007 Bourne C, Roy S, Wiley JL, Martin BR, Thomas BF, Mahadevan A, Razdan RK. Novel, potent THC/anandamide (hybrid) analogs. Bioorganic & Medicinal Chemistry. 15: 7850-64. PMID 17827022 DOI: 10.1016/J.Bmc.2007.08.039  0.517
2007 Gehani NC, Nalwalk JW, Razdan RK, Martin BR, Sun X, Wentland M, Abood ME, Hough LB. Significance of cannabinoid CB1 receptors in improgan antinociception. The Journal of Pain : Official Journal of the American Pain Society. 8: 850-60. PMID 17644043 DOI: 10.1016/J.Jpain.2007.05.015  0.439
2007 Niyuhire F, Varvel SA, Martin BR, Lichtman AH. Exposure to marijuana smoke impairs memory retrieval in mice. The Journal of Pharmacology and Experimental Therapeutics. 322: 1067-75. PMID 17586723 DOI: 10.1124/Jpet.107.119594  0.777
2007 Varvel SA, Martin BR, Lichtman AH. Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine. Psychopharmacology. 193: 511-9. PMID 17497137 DOI: 10.1007/S00213-007-0811-2  0.774
2007 Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology. 192: 61-70. PMID 17279376 DOI: 10.1007/S00213-006-0689-4  0.782
2007 Crocker PJ, Mahadevan A, Wiley JL, Martin BR, Razdan RK. The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids. Bioorganic & Medicinal Chemistry Letters. 17: 1504-7. PMID 17257842 DOI: 10.1016/J.Bmcl.2007.01.006  0.565
2007 Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH, Martin BR, Razdan RK. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo. British Journal of Pharmacology. 150: 586-94. PMID 17245367 DOI: 10.1038/Sj.Bjp.0707124  0.768
2007 Wise LE, Shelton CC, Cravatt BF, Martin BR, Lichtman AH. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. European Journal of Pharmacology. 557: 44-8. PMID 17217945 DOI: 10.1016/J.Ejphar.2006.11.002  0.794
2007 Vann RE, Cook CD, Martin BR, Wiley JL. Cannabimimetic properties of ajulemic acid. The Journal of Pharmacology and Experimental Therapeutics. 320: 678-86. PMID 17105826 DOI: 10.1124/Jpet.106.111625  0.657
2007 Ivy Carroll F, Ma W, Navarro HA, Abraham P, Wolckenhauer SA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs. Bioorganic & Medicinal Chemistry. 15: 678-85. PMID 17098430 DOI: 10.1016/J.Bmc.2006.10.061  0.34
2007 Samudre S, Lattanzio FA, Martin BR, Castillo I, Hosseini A, Frazier M, Williams PB. Ocular Pharmacokinetics and Pharmacodynamics of Synthetic Cannabinoid, O‐1812, in a Perfused Rat Eye Model The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A417-C  0.493
2006 Wiley JL, Razdan RK, Martin BR. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Life Sciences. 80: 24-35. PMID 16978656 DOI: 10.1016/J.Lfs.2006.08.017  0.573
2006 Wilson DM, Varvel SA, Harloe JP, Martin BR, Lichtman AH. SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice. Pharmacology, Biochemistry, and Behavior. 85: 105-13. PMID 16934319 DOI: 10.1016/J.Pbb.2006.07.018  0.795
2006 Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic & Medicinal Chemistry Letters. 16: 5432-5. PMID 16889960 DOI: 10.1016/J.Bmcl.2006.07.051  0.596
2006 Sim-Selley LJ, Schechter NS, Rorrer WK, Dalton GD, Hernandez J, Martin BR, Selley DE. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Molecular Pharmacology. 70: 986-96. PMID 16760363 DOI: 10.1124/Mol.105.019612  0.396
2006 Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK. Pharmacological characterization of novel water-soluble cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 318: 1230-9. PMID 16757541 DOI: 10.1124/Jpet.106.104109  0.638
2006 Carroll FI, Hu X, Navarro HA, Deschamps J, Abdrakhmanova GR, Damaj MI, Martin BR. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes. Journal of Medicinal Chemistry. 49: 3244-50. PMID 16722642 DOI: 10.1021/Jm060122N  0.375
2006 Varvel SA, Wiley JL, Yang R, Bridgen DT, Long K, Lichtman AH, Martin BR. Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology. 186: 226-34. PMID 16572263 DOI: 10.1007/S00213-006-0356-9  0.805
2006 Abdrakhmanova GR, Damaj MI, Carroll FI, Martin BR. 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs. Molecular Pharmacology. 69: 1945-52. PMID 16505153 DOI: 10.1124/Mol.105.021782  0.357
2006 Blair RE, Deshpande LS, Sombati S, Falenski KW, Martin BR, DeLorenzo RJ. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. The Journal of Pharmacology and Experimental Therapeutics. 317: 1072-8. PMID 16469864 DOI: 10.1124/Jpet.105.100354  0.371
2006 Bisogno T, Cascio MG, Saha B, Mahadevan A, Urbani P, Minassi A, Appendino G, Saturnino C, Martin B, Razdan R, Di Marzo V. Development of the first potent and specific inhibitors of endocannabinoid biosynthesis Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids. 1761: 205-212. PMID 16466961 DOI: 10.1016/J.Bbalip.2005.12.009  0.313
2006 Grabus SD, Martin BR, Brown SE, Damaj MI. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology. 184: 456-63. PMID 16463055 DOI: 10.1007/S00213-006-0305-7  0.369
2006 Marriott KS, Huffman JW, Wiley JL, Martin BR. Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor. Bioorganic & Medicinal Chemistry. 14: 2386-97. PMID 16321538 DOI: 10.1016/J.Bmc.2005.11.023  0.586
2006 Ligresti A, Cascio MG, Pryce G, Kulasegram S, Beletskaya I, De Petrocellis L, Saha B, Mahadevan A, Visintin C, Wiley JL, Baker D, Martin BR, Razdan RK, Di Marzo V. New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. British Journal of Pharmacology. 147: 83-91. PMID 16284631 DOI: 10.1038/Sj.Bjp.0706418  0.548
2006 Huffman JW, Bushell SM, Joshi SN, Wiley JL, Martin BR. Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor. Bioorganic & Medicinal Chemistry. 14: 247-62. PMID 16165365 DOI: 10.1016/J.Bmc.2005.08.013  0.601
2006 Lichtman AH, Martin BR. Understanding the pharmacology and physiology of cannabis dependence Cannabis Dependence: Its Nature, Consequences, and Treatment. 37-57. DOI: 10.1017/CBO9780511544248.005  0.581
2005 Lichtman AH, Martin BR. Cannabinoid tolerance and dependence. Handbook of Experimental Pharmacology. 691-717. PMID 16596793 DOI: 10.1007/3-540-26573-2_24  0.621
2005 Carroll FI, Brieaddy LE, Navarro HA, Damaj MI, Martin BR. Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues. Journal of Medicinal Chemistry. 48: 7491-5. PMID 16279810 DOI: 10.1021/Jm058243V  0.365
2005 Damaj MI, Wiley JL, Martin BR, Papke RL. In vivo characterization of a novel inhibitor of CNS nicotinic receptors. European Journal of Pharmacology. 521: 43-8. PMID 16181622 DOI: 10.1016/J.Ejphar.2005.06.056  0.543
2005 Huffman JW, Szklennik PV, Almond A, Bushell K, Selley DE, He H, Cassidy MP, Wiley JL, Martin BR. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorganic & Medicinal Chemistry Letters. 15: 4110-3. PMID 16005223 DOI: 10.1016/J.Bmcl.2005.06.008  0.604
2005 Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. The Journal of Pharmacology and Experimental Therapeutics. 314: 329-37. PMID 15831444 DOI: 10.1124/Jpet.104.080739  0.804
2005 Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A, Martin BR. CB1 cannabinoid receptor-mediated modulation of food intake in mice. British Journal of Pharmacology. 145: 293-300. PMID 15778743 DOI: 10.1038/Sj.Bjp.0706157  0.554
2005 Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, Thompson AL, Bushell S, Tartal C, Hurst DP, Reggio PH, Selley DE, Cassidy MP, Wiley JL, Martin BR. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorganic & Medicinal Chemistry. 13: 89-112. PMID 15582455 DOI: 10.1016/J.Bmc.2004.09.050  0.612
2005 Alekseeva OO, Mahadevan A, Wiley JL, Martin BR, Razdan RK. Synthesis of novel 5-substituted pyrazole derivatives as cannabinoid antagonists Tetrahedron Letters. 46: 2159-2161. DOI: 10.1016/J.Tetlet.2005.01.165  0.546
2004 Damaj MI, Hunter RG, Martin BR, Kuhar MJ. Intrathecal CART (55-102) enhances the spinal analgesic actions of morphine in mice. Brain Research. 1024: 146-9. PMID 15451376 DOI: 10.1016/J.Brainres.2004.07.058  0.365
2004 Martin BR, Wiley JL. Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain. The Journal of Supportive Oncology. 2: 305-14; discussion 3. PMID 15357514  0.444
2004 Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Molecular Pharmacology. 66: 675-82. PMID 15322260 DOI: 10.1124/Mol.104.001313  0.356
2004 Carroll FI, Ware R, Brieaddy LE, Navarro HA, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist. Journal of Medicinal Chemistry. 47: 4588-94. PMID 15317468 DOI: 10.1021/Jm040078G  0.424
2004 Wiley JL, LaVecchia KL, Karp NE, Kulasegram S, Mahadevan A, Razdan RK, Martin BR. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. Experimental and Clinical Psychopharmacology. 12: 173-9. PMID 15301634 DOI: 10.1037/1064-1297.12.3.173  0.557
2004 Bass CE, Welch SP, Martin BR. Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors. European Journal of Pharmacology. 496: 99-108. PMID 15288581 DOI: 10.1016/J.Ejphar.2004.06.009  0.628
2004 Selley DE, Cassidy MP, Martin BR, Sim-Selley LJ. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum. Molecular Pharmacology. 66: 1275-84. PMID 15286206 DOI: 10.1124/Mol.104.000604  0.377
2004 Martin BR, Sim-Selley LJ, Selley DE. Signaling pathways involved in the development of cannabinoid tolerance. Trends in Pharmacological Sciences. 25: 325-30. PMID 15165748 DOI: 10.1016/J.Tips.2004.04.005  0.339
2004 Baskfield CY, Martin BR, Wiley JL. Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice. The Journal of Pharmacology and Experimental Therapeutics. 309: 86-91. PMID 14718593 DOI: 10.1124/Jpet.103.055376  0.797
2003 Simsek R, Chang-Fong J, Lee M, Dukat M, Imad Damaj M, Martin BR, Glennon RA. Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 13: 2917-20. PMID 14611857 DOI: 10.1016/S0960-894X(03)00585-7  0.413
2003 Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. The Journal of Pharmacology and Experimental Therapeutics. 307: 129-37. PMID 12954810 DOI: 10.1124/Jpet.103.051920  0.308
2003 Damaj MI, Martin BR, Kuhar MJ. Antinociceptive effects of supraspinal rat cart (55-102) peptide in mice. Brain Research. 983: 233-6. PMID 12914986 DOI: 10.1016/S0006-8993(03)03094-4  0.34
2003 Wiley JL, Martin BR. Cannabinoid pharmacological properties common to other centrally acting drugs. European Journal of Pharmacology. 471: 185-93. PMID 12826237 DOI: 10.1016/S0014-2999(03)01856-9  0.618
2003 Huffman JW, Miller JR, Liddle J, Yu S, Thomas BF, Wiley JL, Martin BR. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols. Bioorganic & Medicinal Chemistry. 11: 1397-410. PMID 12628666 DOI: 10.1016/S0968-0896(02)00649-1  0.599
2003 Offertáler L, Mo FM, Bátkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Molecular Pharmacology. 63: 699-705. PMID 12606780 DOI: 10.1124/Mol.63.3.699  0.387
2003 Huffman JW, Mabon R, Wu MJ, Lu J, Hart R, Hurst DP, Reggio PH, Wiley JL, Martin BR. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. Bioorganic & Medicinal Chemistry. 11: 539-49. PMID 12538019 DOI: 10.1016/S0968-0896(02)00451-0  0.594
2003 Breivogel CS, Scates SM, Beletskaya IO, Lowery OB, Aceto MD, Martin BR. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors. European Journal of Pharmacology. 459: 139-50. PMID 12524139 DOI: 10.1016/S0014-2999(02)02854-6  0.439
2003 Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation. European Journal of Pharmacology. 459: 83-95. PMID 12505537 DOI: 10.1016/S0014-2999(02)02815-7  0.426
2002 Wiley JL, Martin BR. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. Chemistry and Physics of Lipids. 121: 57-63. PMID 12505690 DOI: 10.1016/S0009-3084(02)00146-9  0.644
2002 Huffman JW, Bushell SM, Miller JR, Wiley JL, Martin BR. 1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor. Bioorganic & Medicinal Chemistry. 10: 4119-29. PMID 12413866 DOI: 10.1016/S0968-0896(02)00331-0  0.605
2002 Lichtman AH, Martin BR. Marijuana withdrawal syndrome in the animal model. Journal of Clinical Pharmacology. 42: 20S-27S. PMID 12412832 DOI: 10.1002/J.1552-4604.2002.Tb05999.X  0.672
2002 Bass CE, Griffin G, Grier M, Mahadevan A, Razdan RK, Martin BR. SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study. Pharmacology, Biochemistry, and Behavior. 74: 31-40. PMID 12376150 DOI: 10.1016/S0091-3057(02)00945-0  0.676
2002 Carroll FI, Lee JR, Navarro HA, Ma W, Brieaddy LE, Abraham P, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues. Journal of Medicinal Chemistry. 45: 4755-61. PMID 12361403 DOI: 10.1021/Jm0202268  0.393
2002 Dukat M, El-Zahabi M, Ferretti G, Damaj MI, Martin BR, Young R, Glennon RA. (-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine. Bioorganic & Medicinal Chemistry Letters. 12: 3005-7. PMID 12270194 DOI: 10.1016/S0960-894X(02)00614-5  0.39
2002 Sim-Selley LJ, Martin BR. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. The Journal of Pharmacology and Experimental Therapeutics. 303: 36-44. PMID 12235230 DOI: 10.1124/Jpet.102.035618  0.484
2002 Wiley JL, Jefferson RG, Griffin G, Liddle J, Yu S, Huffman JW, Martin BR. Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity. Pharmacology. 66: 89-99. PMID 12207116 DOI: 10.1159/000065631  0.645
2002 McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics. 302: 451-65. PMID 12130702 DOI: 10.1124/Jpet.102.033506  0.33
2002 Wilson DM, Peart J, Martin BR, Bridgen DT, Byron PR, Lichtman AH. Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler. Drug and Alcohol Dependence. 67: 259-67. PMID 12127197 DOI: 10.1016/S0376-8716(02)00078-9  0.741
2002 McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 100: 627-34. PMID 12091357 DOI: 10.1182/Blood-2002-01-0098  0.327
2002 Lichtman AH, Varvel SA, Martin BR. Endocannabinoids in cognition and dependence. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 66: 269-85. PMID 12052042 DOI: 10.1054/Plef.2001.0351  0.77
2002 Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews. 54: 161-202. PMID 12037135 DOI: 10.1124/Pr.54.2.161  0.564
2002 Wiley JL, Lavecchia KL, Martin BR, Damaj MI. Nicotine-like discriminative stimulus effects of bupropion in rats. Experimental and Clinical Psychopharmacology. 10: 129-35. PMID 12022798 DOI: 10.1037//1064-1297.10.2.129  0.501
2002 Wiley JL, Beletskaya ID, Ng EW, Dai Z, Crocker PJ, Mahadevan A, Razdan RK, Martin BR. Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists. The Journal of Pharmacology and Experimental Therapeutics. 301: 679-89. PMID 11961073 DOI: 10.1124/Jpet.301.2.679  0.621
2002 Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. The Journal of Pharmacology and Experimental Therapeutics. 300: 984-91. PMID 11861807 DOI: 10.1124/Jpet.300.3.984  0.448
2002 Martin BR, Jefferson RG, Winckler R, Wiley JL, Thomas BF, Crocker PJ, Williams W, Razdan RK. Assessment of structural commonality between tetrahydrocannabinol and anandamide. European Journal of Pharmacology. 435: 35-42. PMID 11790376 DOI: 10.1016/S0014-2999(01)01527-8  0.579
2001 Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. European Journal of Pharmacology. 428: 51-7. PMID 11779037 DOI: 10.1016/S0014-2999(01)01243-2  0.575
2001 Carroll FI, Lee JR, Navarro HA, Brieaddy LE, Abraham P, Damaj MI, Martin BR. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist. Journal of Medicinal Chemistry. 44: 4039-41. PMID 11708907 DOI: 10.1021/Jm015561V  0.427
2001 Huffman JW, Lu J, Hynd G, Wiley JL, Martin BR. A pyridone analogue of traditional cannabinoids. A new class of selective ligands for the CB(2) receptor. Bioorganic & Medicinal Chemistry. 9: 2863-70. PMID 11597467 DOI: 10.1016/S0968-0896(01)00155-9  0.563
2001 Varvel SA, Hamm RJ, Martin BR, Lichtman AH. Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology. 157: 142-50. PMID 11594438 DOI: 10.1007/s002130100780  0.752
2001 Lichtman AH, Sheikh SM, Loh HH, Martin BR. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. The Journal of Pharmacology and Experimental Therapeutics. 298: 1007-14. PMID 11504797  0.658
2001 Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States of America. 98: 9371-6. PMID 11470906 DOI: 10.1073/Pnas.161191698  0.68
2001 Lichtman AH, Fisher J, Martin BR. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine. Pharmacology, Biochemistry, and Behavior. 69: 181-8. PMID 11420084 DOI: 10.1016/S0091-3057(01)00514-7  0.675
2001 Breivogel CS, Griffin G, Di Marzo V, Martin BR. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology. 60: 155-63. PMID 11408610 DOI: 10.1124/Mol.60.1.155  0.387
2001 Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR. The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug and Alcohol Dependence. 63: 107-16. PMID 11376914 DOI: 10.1016/S0376-8716(00)00205-2  0.74
2001 Wiley JL, Jefferson RG, Grier MC, Mahadevan A, Razdan RK, Martin BR. Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation. The Journal of Pharmacology and Experimental Therapeutics. 296: 1013-22. PMID 11181936  0.611
2001 Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands. Biochemical and Biophysical Research Communications. 281: 444-51. PMID 11181068 DOI: 10.1006/Bbrc.2001.4354  0.388
2001 Griffin G, Williams S, Aung MM, Razdan RK, Martin BR, Abood ME. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues. British Journal of Pharmacology. 132: 525-35. PMID 11159703 DOI: 10.1038/Sj.Bjp.0703827  0.4
2000 Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Chain-lengthened and imidazoline analogues of nicotine. Bioorganic & Medicinal Chemistry Letters. 10: 2665-8. PMID 11128647 DOI: 10.1016/S0960-894X(00)00541-2  0.346
2000 Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. Journal of Neurochemistry. 75: 2434-44. PMID 11080195 DOI: 10.1046/J.1471-4159.2000.0752434.X  0.446
2000 Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology. 39: 2785-91. PMID 11044748 DOI: 10.1016/S0028-3908(00)00139-8  0.374
2000 Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK, Martin BR. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. European Journal of Pharmacology. 406: 363-74. PMID 11040343 DOI: 10.1016/S0014-2999(00)00687-7  0.466
2000 Mahadevan A, Siegel C, Martin BR, Abood ME, Beletskaya I, Razdan RK. Novel cannabinol probes for CB1 and CB2 cannabinoid receptors. Journal of Medicinal Chemistry. 43: 3778-85. PMID 11020293 DOI: 10.1021/Jm0001572  0.402
2000 Wiley JL, Dewey MA, Jefferson RG, Winckler RL, Bridgen DT, Willoughby KA, Martin BR. Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sciences. 67: 1573-83. PMID 10983852 DOI: 10.1016/S0024-3205(00)00749-9  0.528
2000 Aung MM, Griffin G, Huffman JW, Wu M, Keel C, Yang B, Showalter VM, Abood ME, Martin BR. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug and Alcohol Dependence. 60: 133-40. PMID 10940540 DOI: 10.1016/S0376-8716(99)00152-0  0.354
2000 Bass CE, Martin BR. Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug and Alcohol Dependence. 60: 113-9. PMID 10940538 DOI: 10.1016/S0376-8716(99)00150-7  0.68
2000 Lichtman AH, Peart J, Poklis JL, Bridgen DT, Razdan RK, Wilson DM, Poklis A, Meng Y, Byron PR, Martin BR. Pharmacological evaluation of aerosolized cannabinoids in mice. European Journal of Pharmacology. 399: 141-9. PMID 10884513 DOI: 10.1016/S0014-2999(00)00321-6  0.815
2000 Wiley JL, Patrick GS, Crocker PC, Saha B, Razdan RK, Martin BR. Antinociceptive effects of tetrahydrocannabinol side chain analogs: dependence upon route of administration. European Journal of Pharmacology. 397: 319-26. PMID 10844130 DOI: 10.1016/S0014-2999(00)00259-4  0.579
2000 Huffman JW, Lu J, Dai D, Kitaygorodskiy A, Wiley JL, Martin BR. Synthesis and pharmacology of a hybrid cannabinoid. Bioorganic & Medicinal Chemistry. 8: 439-47. PMID 10722167 DOI: 10.1016/S0968-0896(99)00305-3  0.568
2000 Beardsley PM, Martin BR. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal. European Journal of Pharmacology. 387: 47-53. PMID 10633159 DOI: 10.1016/S0014-2999(99)00792-X  0.405
1999 Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, Martin BR. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorganic & Medicinal Chemistry. 7: 2905-14. PMID 10658595 DOI: 10.1016/S0968-0896(99)00219-9  0.606
1999 Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proceedings of the National Academy of Sciences of the United States of America. 96: 14136-41. PMID 10570211 DOI: 10.1073/pnas.96.24.14136  0.31
1999 Wiley JL, Martin BR. Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination. Pharmacology, Biochemistry, and Behavior. 64: 519-22. PMID 10548265 DOI: 10.1016/S0091-3057(99)00130-6  0.604
1999 Griffin G, Wray EJ, Martin BR, Abood ME. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British Journal of Pharmacology. 128: 684-8. PMID 10516649 DOI: 10.1038/Sj.Bjp.0702806  0.388
1999 Flammia D, Dukat M, Damaj MI, Martin B, Glennon RA. Lobeline: Structure-affinity investigation of nicotinic acetylcholinergic receptor binding Journal of Medicinal Chemistry. 42: 3726-3731. PMID 10479304 DOI: 10.1021/Jm990286M  0.364
1999 Martin BR, Jefferson R, Winckler R, Wiley JL, Huffman JW, Crocker PJ, Saha B, Razdan RK. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists. The Journal of Pharmacology and Experimental Therapeutics. 290: 1065-79. PMID 10454479  0.558
1999 Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. European Journal of Pharmacology. 377: 117-25. PMID 10448934 DOI: 10.1016/S0014-2999(99)00402-1  0.376
1999 Ng EW, Aung MM, Abood ME, Martin BR, Razdan RK. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. Journal of Medicinal Chemistry. 42: 1975-81. PMID 10354405 DOI: 10.1021/Jm980711W  0.331
1999 Griffin G, Wray EJ, Rorrer WK, Crocker PJ, Ryan WJ, Saha B, Razdan RK, Martin BR, Abood ME. An investigation into the structural determinants of cannabinoid receptor ligand efficacy. British Journal of Pharmacology. 126: 1575-84. PMID 10323589 DOI: 10.1038/Sj.Bjp.0702469  0.349
1999 Meng Y, Dukat M, Bridgen DT, Martin BR, Lichtman AH. Pharmacological effects of methamphetamine and other stimulants via inhalation exposure. Drug and Alcohol Dependence. 53: 111-20. PMID 10080037 DOI: 10.1016/S0376-8716(98)00120-3  0.786
1999 Crocker PJ, Saha B, Ryan WJ, Wiley JL, Martin BR, Ross RA, Pertwee RG, Razdan RK. Development of agonists, partial agonists and antagonists in the Δ8-Tetrahydrocannabinol series Tetrahedron. 55: 13907-13926. DOI: 10.1016/S0040-4020(99)00849-2  0.373
1999 Levin ED, Imad Damaj M, Glassco W, May EL, Martin BR. Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze Drug Development Research. 46: 107-111. DOI: 10.1002/(Sici)1098-2299(199902)46:2<107::Aid-Ddr3>3.0.Co;2-C  0.345
1998 Martin BR, Lichtman AH. Cannabinoid transmission and pain perception. Neurobiology of Disease. 5: 447-61. PMID 9974177 DOI: 10.1006/Nbdi.1998.0218  0.589
1998 Huffman JW, Liddle J, Duncan SG, Yu S, Martin BR, Wiley JL. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols. Bioorganic & Medicinal Chemistry. 6: 2383-96. PMID 9925296 DOI: 10.1016/S0968-0896(98)80014-X  0.546
1998 Liddle J, Huffman JW, Wiley JL, Martin BR. Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-delta 8-THC. Bioorganic & Medicinal Chemistry Letters. 8: 2223-6. PMID 9873517 DOI: 10.1016/S0960-894X(98)00385-0  0.518
1998 Lichtman AH, Wiley JL, LaVecchia KL, Neviaser ST, Arthur DB, Wilson DM, Martin BR. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. European Journal of Pharmacology. 357: 139-48. PMID 9797029 DOI: 10.1016/S0014-2999(98)00558-5  0.725
1998 Singer M, Ryan WJ, Saha B, Martin BR, Razdan RK. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol. Journal of Medicinal Chemistry. 41: 4400-7. PMID 9784115 DOI: 10.1021/Jm9803875  0.309
1998 Wiley JL, Ryan WJ, Razdan RK, Martin BR. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. European Journal of Pharmacology. 355: 113-8. PMID 9760024 DOI: 10.1016/S0014-2999(98)00502-0  0.612
1998 Cook SA, Lowe JA, Martin BR. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 285: 1150-6. PMID 9618417  0.333
1998 Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 285: 995-1004. PMID 9618400  0.548
1998 Adams IB, Compton DR, Martin BR. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 284: 1209-17. PMID 9495885  0.32
1997 Wiley JL, Golden KM, Ryan WJ, Balster RL, Razdan RK, Martin BR. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 58: 1139-43. PMID 9408225 DOI: 10.1016/S0091-3057(97)00327-4  0.613
1997 Compton DR, Martin BR. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. The Journal of Pharmacology and Experimental Therapeutics. 283: 1138-43. PMID 9399986  0.329
1997 Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature. 390: 518-21. PMID 9394002 DOI: 10.1038/37371  0.376
1997 Reggio PH, Wang T, Brown AE, Fleming DN, Seltzman HH, Griffin G, Pertwee RG, Compton DR, Abood ME, Martin BR. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs. Journal of Medicinal Chemistry. 40: 3312-8. PMID 9379452 DOI: 10.1021/Jm970136G  0.374
1997 Seltzman HH, Fleming DN, Thomas BF, Gilliam AF, McCallion DS, Pertwee RG, Compton DR, Martin BR. Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. Journal of Medicinal Chemistry. 40: 3626-34. PMID 9357529 DOI: 10.1021/Jm9702950  0.392
1997 Ryan WJ, Banner WK, Wiley JL, Martin BR, Razdan RK. Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. Journal of Medicinal Chemistry. 40: 3617-25. PMID 9357528 DOI: 10.1021/jm970212f  0.497
1997 Dutta AK, Ryan W, Thomas BF, Singer M, Compton DR, Martin BR, Razdan RK. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs). Bioorganic & Medicinal Chemistry. 5: 1591-600. PMID 9313864 DOI: 10.1016/S0968-0896(97)00111-9  0.391
1997 Meng Y, Lichtman AH, Bridgen DT, Martin BR. Inhalation studies with drugs of abuse. Nida Research Monograph. 173: 201-24. PMID 9260190  0.555
1997 Damaj MI, Patrick GS, Creasy KR, Martin BR. Pharmacology of lobeline, a nicotinic receptor ligand. The Journal of Pharmacology and Experimental Therapeutics. 282: 410-9. PMID 9223582  0.332
1997 Lake KD, Compton DR, Varga K, Martin BR, Kunos G. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. The Journal of Pharmacology and Experimental Therapeutics. 281: 1030-7. PMID 9190833  0.344
1997 Lichtman AH, Martin BR. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Pharmacology, Biochemistry, and Behavior. 57: 7-12. PMID 9164547 DOI: 10.1016/S0091-3057(96)00121-9  0.69
1997 Lake KD, Martin BR, Kunos G, Varga K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension. 29: 1204-10. PMID 9149688 DOI: 10.1161/01.Hyp.29.5.1204  0.323
1997 Huffman JW, Duncan SG, Wiley JL, Martin BR. Synthesis and pharmacology of the 1',2'-dimethylheptyl-Δ8-THC isomers: Exceptionally potent cannabinoids Bioorganic and Medicinal Chemistry Letters. 7: 2799-2804. DOI: 10.1016/S0960-894X(97)10086-5  0.528
1997 Ryan WJ, Banner WK, Crocker PJ, Martin BR, Razdan RK. Synthesis of (+)- and (-)-2-methylarachidonyl-2'-fluoroethylamide (O-689) Bioorganic & Medicinal Chemistry Letters. 7: 2669-2672. DOI: 10.1016/S0960-894X(97)10047-6  0.347
1997 Singer M, Dutta AK, Compton DR, Martin BR, Razdan RK. Synthesis and pharmacology of (R)- and (S)-4'-hydroxy-Δ9-tetrahydrocannabinols European Journal of Medicinal Chemistry. 32: 165-170. DOI: 10.1016/S0223-5234(97)87544-7  0.309
1997 Huffman JW, Lainton JAH, Banner WK, Duncan SG, Jordan RD, Yu S, Dai D, Martin BR, Wiley JL, Compton DR. Side chain methyl analogues of Δ8-THC Tetrahedron. 53: 1557-1576. DOI: 10.1016/S0040-4020(96)01134-9  0.524
1996 Wiley JL, Compton DR, Gordon PM, Siegel C, Singer M, Dutta A, Lichtman AH, Balster RL, Razdan RK, Martin BR. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol. Neuropharmacology. 35: 1793-804. PMID 9076759 DOI: 10.1016/S0028-3908(96)00120-7  0.775
1996 Pertwee RG, Fernando SR, Griffin G, Ryan W, Razdan RK, Compton DR, Martin BR. Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. European Journal of Pharmacology. 315: 195-201. PMID 8960884 DOI: 10.1016/S0014-2999(96)00631-0  0.372
1996 Meng Y, Lichtman AH, Bridgen DT, Martin BR. Pharmacological potency and biodisposition of phencyclidine via inhalation exposure in mice. Drug and Alcohol Dependence. 43: 13-22. PMID 8957139 DOI: 10.1016/S0376-8716(96)01284-7  0.797
1996 Abood ME, Martin BR. Molecular neurobiology of the cannabinoid receptor International Review of Neurobiology. 197-221. PMID 8894848 DOI: 10.1016/S0074-7742(08)60667-4  0.382
1996 Lichtman AH, Meng Y, Martin BR. Inhalation exposure to volatilized opioids produces antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 279: 69-76. PMID 8858977  0.649
1996 Lichtman AH, Martin BR. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology. 126: 125-31. PMID 8856831 DOI: 10.1007/Bf02246347  0.647
1996 Huffman JW, Yu S, Showalter V, Abood ME, Wiley JL, Compton DR, Martin BR, Bramblett RD, Reggio PH. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. Journal of Medicinal Chemistry. 39: 3875-7. PMID 8831752 DOI: 10.1021/Jm960394Y  0.603
1996 Damaj MI, Martin BR. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice. European Journal of Pharmacology. 300: 51-7. PMID 8741164 DOI: 10.1016/0014-2999(95)00834-9  0.398
1996 Fan F, Tao Q, Abood M, Martin BR. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice Brain Research. 706: 13-20. PMID 8720487 DOI: 10.1016/0006-8993(95)01113-7  0.463
1996 Lichtman AH, Cook SA, Martin BR. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. The Journal of Pharmacology and Experimental Therapeutics. 276: 585-93. PMID 8632325  0.649
1996 Shivachar AC, Martin BR, Ellis EF. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. Biochemical Pharmacology. 51: 669-76. PMID 8615904 DOI: 10.1016/S0006-2952(95)02248-1  0.354
1996 Dukat M, Fiedler W, Dumas D, Damaj I, Martin BR, Rosecrans JA, James JR, Glennon RA. Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure-affinity investigation European Journal of Medicinal Chemistry. 31: 875-888. DOI: 10.1016/S0223-5234(97)89850-9  0.364
1996 Imad Damaj M, Glassco W, Dukat M, May EL, Glennon RA, Martin BR. Pharmacology of novel nicotinic analogs Drug Development Research. 38: 177-187. DOI: 10.1002/(Sici)1098-2299(199607/08)38:3/4<177::Aid-Ddr6>3.0.Co;2-J  0.375
1995 Wiley JL, Huffman JW, Balster RL, Martin BR. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys. Drug and Alcohol Dependence. 40: 81-6. PMID 8746928 DOI: 10.1016/0376-8716(95)01193-5  0.589
1995 Damaj MI, Creasy KR, Welch SP, Rosecrans JA, Aceto MD, Martin BR. Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist. Psychopharmacology. 120: 483-90. PMID 8539331 DOI: 10.1007/Bf02245822  0.36
1995 Martin BR, Compton DR, Prescott WR, Barrett RL, Razdan RK. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction. Drug and Alcohol Dependence. 37: 231-40. PMID 7796717 DOI: 10.1016/0376-8716(94)01081-U  0.405
1995 Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. The Journal of Pharmacology and Experimental Therapeutics. 273: 1172-81. PMID 7791088  0.302
1995 Wiley J, Balster R, Martin B. Discriminative stimulus effects of anandamide in rats. European Journal of Pharmacology. 276: 49-54. PMID 7781695 DOI: 10.1016/0014-2999(95)00010-I  0.441
1995 Wenger T, Tóth BE, Martin BR. Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sciences. 56: 2057-63. PMID 7776832 DOI: 10.1016/0024-3205(95)00189-D  0.301
1995 Cook SA, Welch SP, Lichtman AH, Martin BR. Evaluation of cAMP involvement in cannabinoid-induced antinociception. Life Sciences. 56: 2049-56. PMID 7776831 DOI: 10.1016/0024-3205(95)00188-C  0.681
1995 Adams IB, Ryan W, Singer M, Razdan RK, Compton DR, Martin BR. Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sciences. 56: 2041-8. PMID 7776830 DOI: 10.1016/0024-3205(95)00187-B  0.377
1995 Ryan W, Singer M, Razdan RK, Compton DR, Martin BR. A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS. Life Sciences. 56: 2013-20. PMID 7776826 DOI: 10.1016/0024-3205(95)00183-7  0.428
1995 Damaj MI, Welch SP, Martin BR. In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice Psychopharmacology. 117: 67-73. PMID 7724704 DOI: 10.1007/Bf02245100  0.37
1995 Lichtman AH, Dimen KR, Martin BR. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology. 119: 282-90. PMID 7675962 DOI: 10.1007/Bf02246292  0.648
1995 Glennon RA, Young R, Martin BR, Dal Cason TA. Methcathinone ("cat"): An enantiomeric potency comparison Pharmacology, Biochemistry and Behavior. 50: 601-606. PMID 7617707 DOI: 10.1016/0091-3057(94)00348-3  0.324
1995 Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology. 50: 83-90. PMID 7605349 DOI: 10.1016/0006-2952(95)00109-D  0.377
1995 Varga K, Lake K, Martin BR, Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. European Journal of Pharmacology. 278: 279-83. PMID 7589169 DOI: 10.1016/0014-2999(95)00181-J  0.404
1995 Barrett RL, Wiley JL, Balster RL, Martin BR. Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology. 118: 419-24. PMID 7568628 DOI: 10.1007/Bf02245942  0.605
1995 Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology. 34: 669-76. PMID 7566504 DOI: 10.1016/0028-3908(95)00027-4  0.617
1995 Wiley JL, Lowe JA, Balster RL, Martin BR. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 275: 1-6. PMID 7562536  0.588
1995 Lichtman AH, Sathe P, Dimen KR, Martin BR. Acute tolerance to the cardiovascular effects of volatilized cocaine free base in rats. Drug and Alcohol Dependence. 38: 247-54. PMID 7555625 DOI: 10.1016/0376-8716(95)01111-B  0.594
1994 Damaj MI, Glennon RA, Martin BR. Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice. Brain Research Bulletin. 33: 199-203. PMID 8275340 DOI: 10.1016/0361-9230(94)90252-6  0.377
1994 Martin BR, Welch SP, Abood M. Progress toward Understanding the Cannabinoid Receptor and Its Second Messenger Systems Advances in Pharmacology (San Diego). 25: 341-397. PMID 8204506 DOI: 10.1016/S1054-3589(08)60437-8  0.374
1994 Yan G, Yin D, Khanolkar AD, Compton DR, Martin BR, Makriyannis A. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist. Journal of Medicinal Chemistry. 37: 2619-22. PMID 8057304 DOI: 10.1021/Jm00042A015  0.335
1994 Damaj MI, Welch SP, Martin BR. Nicotine-induced antinociception in mice: Role of G-proteins and adenylate cyclase Pharmacology, Biochemistry and Behavior. 48: 37-42. PMID 8029303 DOI: 10.1016/0091-3057(94)90494-4  0.387
1994 McLaughlin CR, Martin BR, Compton DR, Abood ME. Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug and Alcohol Dependence. 36: 27-31. PMID 7988356 DOI: 10.1016/0376-8716(94)90006-X  0.371
1994 Mechoulam R, Hanuš L, Martin BR. Search for endogenous ligands of the cannabinoid receptor. Biochemical Pharmacology. 48: 1537-1544. PMID 7980618 DOI: 10.1016/0006-2952(94)90197-X  0.321
1994 May EL, Aceto MD, Bowman ER, Bentley C, Martin BR, Harris LS, Medzihradsky F, Mattson MV, Jacobson AE. Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties. Journal of Medicinal Chemistry. 37: 3408-18. PMID 7932569 DOI: 10.1021/Jm00046A026  0.606
1994 Damaj MI, Creasy KR, Grove AD, Rosecrans JA, Martin BR. Pharmacological effects of epibatidine optical enantiomers. Brain Research. 664: 34-40. PMID 7895043 DOI: 10.1016/0006-8993(94)91950-X  0.387
1994 Huffman JW, Dai D, Martin BR, Compton DR. Design, Synthesis and Pharmacology of Cannabimimetic Indoles Bioorganic and Medicinal Chemistry Letters. 4: 563-566. DOI: 10.1016/S0960-894X(01)80155-4  0.355
1994 Lichtman AH, Martin BR. Changes in tail skin temperature are unlikely to be a confounding factor in the tail-flick test Pain. 57: 257-258. DOI: 10.1016/0304-3959(94)90235-6  0.572
1993 Wiley JL, Barrett RL, Balster RL, Martin BR. Tolerance to the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol. Behavioural Pharmacology. 4: 581-585. PMID 11224227  0.534
1993 Wiley JL, Barrett RL, Britt DT, Balster RL, Martin BR. Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys. Neuropharmacology. 32: 359-65. PMID 8388551 DOI: 10.1016/0028-3908(93)90157-X  0.594
1993 Lu R, Hubbard JR, Martin BR, Kalimi MY. Roles of sulfhydryl and disulfide groups in the binding of CP-55,940 to rat brain cannabinoid receptor. Molecular and Cellular Biochemistry. 121: 119-26. PMID 8316228 DOI: 10.1007/Bf00925970  0.368
1993 Abood ME, Sauss C, Fan F, Tilton CL, Martin BR. Development of behavioral tolerance to Δ9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain Pharmacology, Biochemistry and Behavior. 46: 575-579. PMID 8278434 DOI: 10.1016/0091-3057(93)90546-6  0.409
1993 Glassco W, Suchocki J, George C, Martin BR, May EL. Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H- pyrrolo-[3,2-h]isoquinoline, a structural analog of nicotine. Journal of Medicinal Chemistry. 36: 3381-5. PMID 8230128 DOI: 10.1021/Jm00074A019  0.358
1993 Lichtman AH, Smith FL, Martin BR. Evidence that the antinociceptive tail-flick response is produced independently from changes in either tail-skin temperature or core temperature. Pain. 55: 283-95. PMID 8121689 DOI: 10.1016/0304-3959(93)90003-8  0.609
1993 Damaj MI, Martin BR. Is the dopaminergic system involved in the central effects of nicotine in mice Psychopharmacology. 111: 106-108. PMID 7870924 DOI: 10.1007/Bf02257415  0.366
1993 Damaj MI, Martin BR. Calcium agonists and antagonists of the dihydropyridine type: effect on nicotine-induced antinociception and hypomotility. Drug and Alcohol Dependence. 32: 73-9. PMID 7683598 DOI: 10.1016/0376-8716(93)90024-K  0.336
1993 Wiley JL, Barrett RL, Balster RL, Martin BR. Tolerance to the discriminative stimulus effects of Δ9-tetrahydrocannabinol Behavioural Pharmacology. 4: 581-585. DOI: 10.1097/00008877-199312000-00004  0.521
1992 Darmani NA, Martin BR, Glennon RA. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function. Pharmacology, Biochemistry, and Behavior. 41: 519-27. PMID 1584831 DOI: 10.1016/0091-3057(92)90367-O  0.33
1992 Lichtman AH, Smith PB, Martin BR. The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity. Pain. 51: 19-26. PMID 1454400 DOI: 10.1016/0304-3959(92)90004-U  0.681
1992 Darmani NA, Schnoll SH, Pandey U, Martin BR. Chronic prenatal methadone exposure alters central opioid μ-receptor affinity in both fetal and maternal brain Neurotoxicology and Teratology. 14: 265-271. PMID 1326078 DOI: 10.1016/0892-0362(92)90006-V  0.372
1992 Smith PB, Martin BR. Spinal mechanisms ofΔ9-tetrahydrocannabinol-induced analgesia Brain Research. 578: 8-12. PMID 1324767 DOI: 10.1016/0006-8993(92)90222-U  0.341
1992 Charalambous A, Yan G, Houston DB, Howlett AC, Compton DR, Martin BR, Makriyannis A. 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. Journal of Medicinal Chemistry. 35: 3076-9. PMID 1323683 DOI: 10.1021/Jm00094A023  0.594
1992 Carroll FI, Abraham P, Parham K, Bai X, Zhang X, Brine GA, Mascarella SW, Martin BR, May EL, Sauss C. Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors. Journal of Medicinal Chemistry. 35: 2812-8. PMID 1322987 DOI: 10.1021/Jm00093A014  0.381
1992 Prescott WR, Gold LH, Martin BR. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Psychopharmacology. 107: 117-24. PMID 1317040 DOI: 10.1007/Bf02244975  0.373
1991 Darmani NA, Martin BR, Pandey U, Glennon RA. Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions. Pharmacology, Biochemistry, and Behavior. 37: 95-9. PMID 2263671 DOI: 10.1016/0091-3057(90)90047-L  0.364
1991 Glennon RA, Darmani NA, Martin BR. Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents. Life Sciences. 48: 2493-8. PMID 2046474 DOI: 10.1016/0024-3205(91)90603-9  0.318
1991 Suchocki JA, May EL, Martin TJ, George C, Martin BR. Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system. Journal of Medicinal Chemistry. 34: 1003-10. PMID 2002445 DOI: 10.1021/Jm00107A019  0.35
1991 Little PJ, Martin BR. The effects of Δ9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes Life Sciences. 48: 1133-1141. PMID 1848340 DOI: 10.1016/0024-3205(91)90450-P  0.378
1991 Darmani NA, Martin BR, Pandey U, Glennon RA. Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors. Pharmacology, Biochemistry, and Behavior. 38: 353-7. PMID 1676173 DOI: 10.1016/0091-3057(91)90290-I  0.345
1991 Lichtman AH, Martin BR. Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism. Brain Research. 559: 309-14. PMID 1665384 DOI: 10.1016/0006-8993(91)90017-P  0.652
1991 Compton DR, Prescott WR, Martin BR, Siegel C, Gordon PM, Razdan RK. Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. Journal of Medicinal Chemistry. 34: 3310-6. PMID 1659638 DOI: 10.1021/Jm00115A023  0.467
1991 Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoid-induced antinociception. The Journal of Pharmacology and Experimental Therapeutics. 258: 517-23. PMID 1650831  0.589
1991 Darmani NA, Schnoll SH, Fuchs B, Martin BR. Does chronic prenatal methadone exposure affect β-receptor subtypes in placental, fetal and maternal brain homogenates? Neurotoxicology and Teratology. 13: 43-48. PMID 1646380 DOI: 10.1016/0892-0362(91)90026-S  0.312
1990 Compton DR, Martin BR. Pharmacological evaluation of water soluble cannabinoids and related analogs. Life Sciences. 46: 1575-85. PMID 2352451 DOI: 10.1016/0024-3205(90)90391-4  0.329
1990 Compton DR, Dewey WL, Martin BR. Cannabis dependence and tolerance production. Advances in Alcohol & Substance Abuse. 9: 129-47. PMID 2165734 DOI: 10.1300/J251V09N01_08  0.53
1990 Semus SF, Martin BR. A computergraphic investigation into the pharmacological role of the THC-cannabinoid phenolic moiety. Life Sciences. 46: 1781-1785. PMID 2163002 DOI: 10.1016/0024-3205(90)90142-E  0.339
1990 Onaivi ES, Green MR, Martin BR. Pharmacological characterization of cannabinoids in the elevated plus maze. The Journal of Pharmacology and Experimental Therapeutics. 253: 1002-9. PMID 2162942  0.33
1990 Compton DR, Little PJ, Martin BR, Gilman JW, Saha JK, Jorapur VS, Sard HP, Razdan RK. Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol. Journal of Medicinal Chemistry. 33: 1437-43. PMID 2158563 DOI: 10.1021/Jm00167A025  0.416
1990 Todd SL, Balster RL, Martin BR. Affinity of the enantiomers of α- and β-cyclazocine for binding to the phencyclidine and μ opioid receptors Life Sciences. 46: 895-901. PMID 2157122 DOI: 10.1016/0024-3205(90)90120-G  0.347
1990 Darmani NA, Martin BR, Pandey U, Glennon RA. Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacology, Biochemistry, and Behavior. 36: 901-6. PMID 2145593 DOI: 10.1016/0091-3057(90)90098-3  0.325
1990 Lichtman AH, Martin BR. Spinal action of cannabinoid-induced antinociception. Nida Research Monograph. 105: 422-4. PMID 1876060  0.568
1989 Glennon RA, Ismaiel AE, Martin B, Poff D, Sutton M. A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine. Pharmacology, Biochemistry, and Behavior. 31: 9-13. PMID 3252264 DOI: 10.1016/0091-3057(88)90303-6  0.386
1989 Onaivi ES, Todd S, Martin BR. Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration Drug and Alcohol Dependence. 24: 205-211. PMID 2605996 DOI: 10.1016/0376-8716(89)90057-4  0.316
1989 Onaivi ES, Martin BR. Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 13: 963-976. PMID 2573111 DOI: 10.1016/0278-5846(89)90047-X  0.326
1989 Little PJ, Compton DR, Mechoulam R, Martin BR. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs. Pharmacology, Biochemistry, and Behavior. 32: 661-6. PMID 2544901 DOI: 10.1016/0091-3057(89)90014-2  0.408
1989 Compton DR, Little PJ, Martin BR, Saha JK, Gilman J, Sard H, Razdan RK. Synthesis and pharmacological evaluation of mercapto and thioacetyl analogues of cannabidiol and Δ8-tetrahydrocannabinol European Journal of Medicinal Chemistry. 24: 293-297. DOI: 10.1016/0223-5234(89)90012-3  0.352
1988 Lyddane JE, Thomas BF, Compton DR, Martin BR. Modification of phencyclidine intoxification and biodisposition by charcoal and other treatments. Pharmacology, Biochemistry, and Behavior. 30: 371-7. PMID 3174769 DOI: 10.1016/0091-3057(88)90470-4  0.306
1988 Scimeca JA, Martin BR. The Effect of Acute Dyflos (DFP) Treatment on [3H]Nicotine Binding to Mouse Brain Homogenate Journal of Pharmacy and Pharmacology. 40: 793-797. PMID 2907560 DOI: 10.1111/J.2042-7158.1988.Tb05174.X  0.361
1987 Estrada U, Brase DA, Martin BR, Dewey WL. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sciences. 41: 79-87. PMID 3037218 DOI: 10.1016/0024-3205(87)90559-5  0.553
1987 Beardsley PM, Scimeca JA, Martin BR. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics. 241: 521-6. PMID 3033218  0.316
1986 Kachur JF, May EL, Awaya H, Egle JL, Aceto MD, Martin BR. Pharmacological effects of 1,2,3,5,6,10b-hexahydropyrido[2,3g]indolizine, a bridged-nicotine analog. Life Sciences. 38: 323-30. PMID 3945165 DOI: 10.1016/0024-3205(86)90079-2  0.332
1986 Aceto MD, Bagley RS, Dewey WL, Fu TC, Martin BR. The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology. 25: 1031-6. PMID 3774124 DOI: 10.1016/0028-3908(86)90198-X  0.516
1985 Kachur JF, Rosemond R, Welch S, Bowman ER, Martin BR, Brase DA, Dewey WL. Comparison of the ability of opioid analgesics to increase endogenous opioid-like activity in the cerebrospinal fluid of rabbits. Life Sciences. 37: 2549-55. PMID 4079662 DOI: 10.1016/0024-3205(85)90613-7  0.546
1985 Reynolds ML, Little PJ, Thomas BF, Bagley RB, Martin BR. Relationship between the biodisposition of [3H]soman and its pharmacological effects in mice. Toxicology and Applied Pharmacology. 80: 409-20. PMID 4035696 DOI: 10.1016/0041-008X(85)90385-0  0.3
1985 Wessinger WD, Martin BR, Balster RL. Discriminative stimulus properties and brain distribution of phencyclidine in rats following administration by injection and smoke inhalation Pharmacology, Biochemistry and Behavior. 23: 607-612. PMID 2999833 DOI: 10.1016/0091-3057(85)90425-3  0.352
1985 Jorapur VS, Khalil ZH, Duffley RP, Razdan RK, Martin BR, Harris LS, Dewey WL. Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol. Journal of Medicinal Chemistry. 28: 783-7. PMID 2989518 DOI: 10.1021/Jm00383A016  0.67
1985 Martin BR. Structural requirements for cannabinoid-induced antinociceptive activity in mice Life Sciences. 36: 1523-1530. PMID 2984503 DOI: 10.1016/0024-3205(85)90376-5  0.357
1984 Freeman AS, Martin BR, Balster RL. Relationship between the development of behavioral tolerance and the biodisposition of phencyclidine in mice. Pharmacology, Biochemistry, and Behavior. 20: 373-7. PMID 6709671 DOI: 10.1016/0091-3057(84)90273-9  0.377
1984 Martin BR, Reynolds ML, Harris LS, Toro-Goyco E. Binding of [3H]phenycyclidine to rat and human blood constituents. Biochemical Pharmacology. 33: 429-34. PMID 6704162 DOI: 10.1016/0006-2952(84)90236-3  0.495
1984 Robertson LR, Duffley RP, Razdan RK, Martin BR, Harris LS, Dewey WL. Synthesis and pharmacological activity of some 9-substituted delta 8-tetrahydrocannabinol analogues. Journal of Medicinal Chemistry. 27: 550-2. PMID 6323713 DOI: 10.1021/Jm00370A023  0.652
1984 Shook JE, Kallman MJ, Martin BR, Dewey WL. Characterization of the interaction of pentazocine and tripelennamine: drug discrimination and mu-receptor binding assay. Pharmacology, Biochemistry, and Behavior. 21: 877-81. PMID 6097919 DOI: 10.1016/S0091-3057(84)80068-4  0.573
1984 Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 231: 539-44. PMID 6094791  0.454
1984 Martin BR, Kallman MJ, Kaempf GF, Harris LS, Dewey WL, Razdan RK. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity. Pharmacology, Biochemistry, and Behavior. 21: 61-5. PMID 6087379 DOI: 10.1016/0091-3057(84)90131-X  0.648
1983 Rosin DL, Martin BR. Comparison of the effects of acute and subchronic administration of aroclor 1254, a commercial mixture of polychlorinated biphenyls, on pentobarbital‐induced sleep time and [14c]pentobarbital disposition in mice Journal of Toxicology and Environmental Health. 11: 917-931. PMID 6413697 DOI: 10.1080/15287398309530395  0.311
1983 Harris LS, Aceto MD, Balster RL, Martin BR. Progress report: Medical College of Virginia--sigma agonists. Nida Research Monograph. 43: 79-84. PMID 6308455  0.406
1983 Freeman AS, Martin BR. Interactions between phencyclidine and delta 9-tetrahydrocannabinol in mice following smoke exposure. Life Sciences. 32: 1081-9. PMID 6298542 DOI: 10.1016/0024-3205(83)90113-3  0.377
1983 Aceto MD, Awaya H, Martin BR, May EL. Antinociceptive action of nicotine and its methiodide derivatives in mice and rats. British Journal of Pharmacology. 79: 869-76. PMID 6140048 DOI: 10.1111/J.1476-5381.1983.Tb10531.X  0.317
1983 Dewey WL, Bowman E, Jones D, Kachur J, Rosemond R, Welch S, Martin BR. Pharmachology The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species Pain. 17: 393. DOI: 10.1016/0304-3959(83)90171-9  0.488
1982 Dewey WL, Bowman E, Jones D, Kachur J, Rosemond R, Welch S, Martin BR. The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species. Life Sciences. 31: 1741-3. PMID 7154834 DOI: 10.1016/0024-3205(82)90199-0  0.554
1982 Handrick GR, Duffley RP, Lambert G, Murphy JG, Dalzell HC, Howes JF, Razdan RK, Martin BR, Harris LS, Dewey WL. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol. Journal of Medicinal Chemistry. 25: 1447-50. PMID 6296389  0.629
1982 Dewey WL, Fu TC, Ohlsson A, Bowman E, Martin BR. Evidence for the release of endogenous opiates by morphine. Nida Research Monograph. 41: 60-6. PMID 6289120  0.422
1982 Ohlsson AE, Fu TC, Jones D, Martin BR, Dewey WL. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice. The Journal of Pharmacology and Experimental Therapeutics. 221: 362-7. PMID 6281413  0.45
1981 Vincek WC, Martin BR, Aceto MD, Tripathi HL, May EL, Harris LS. Synthesis of 4,4-ditritio-(+)-nicotine: comparative binding and distribution studies with natural enantiomer. Journal of Pharmaceutical Sciences. 70: 1292-3. PMID 7299682 DOI: 10.1002/JPS.2600701131  0.523
1981 Martin BR, Aceto MD. Nicotine binding sites and their localization in the central nervous system Neuroscience & Biobehavioral Reviews. 5: 473-478. PMID 7033844 DOI: 10.1016/0149-7634(81)90017-8  0.303
1981 Martin BR, Balster RL, Razdan RK, Harris LS, Dewey WL. Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sciences. 29: 565-74. PMID 6268916 DOI: 10.1016/0024-3205(81)90434-3  0.632
1980 Vincek WC, Martin BR, Aceto MD, Bowman ER. Synthesis and preliminary binding studies of 4,4-ditritio-(-)-nicotine of high specific activity. Journal of Medicinal Chemistry. 23: 960-962. PMID 7401120 DOI: 10.1021/Jm00182A028  0.304
1980 Woolverton WL, Martin BR, Balster RL. Modification of the behavioral effects of phencyclidine by repeated drug exposure and body weight changes. Pharmacology, Biochemistry, and Behavior. 12: 761-6. PMID 7393970 DOI: 10.1016/0091-3057(80)90163-X  0.309
1980 Man M, Harris LS, Woods LA, Martin BR. Isotope dilution technique for the estimation of l-alpha-[2-3H]-acetylmethadol and its metabolites in biological samples. Pharmacology. 20: 130-6. PMID 6992151  0.391
1980 Alozie SO, Martin BR, Harris LS, Dewey WL. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain. Pharmacology, Biochemistry, and Behavior. 12: 217-21. PMID 6246544 DOI: 10.1016/0091-3057(80)90359-7  0.612
1980 Man M, Alozie SO, Woods LA, Martin BR, Harris LS. Distribution of l-alpha-[2-3H]acetylmethadol and its metabolites in maternal and fetal rat tissues. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 8: 55-9. PMID 6103787  0.391
1979 Wilson RS, Martin BR, Dewey WL. Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. Journal of Medicinal Chemistry. 22: 879-82. PMID 448686 DOI: 10.1021/JM00193A025  0.557
1979 Aceto MD, Martin BR, Uwaydah IM, May EL, Harris LS, Izazola-Conde C, Dewey WL, Bradshaw TJ, Vincek WC. Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine. Journal of Medicinal Chemistry. 22: 174-7. PMID 423195 DOI: 10.1021/JM00188A009  0.624
1979 Carney JM, Balster RL, Martin BR, Harris LS. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey. The Journal of Pharmacology and Experimental Therapeutics. 210: 399-404. PMID 113528  0.492
1979 Toro-Goyco E, Martin BR, Harris LS. The binding of LAAM and its metabolites to blood constituents. Nida Research Monograph. 27: 54-60. PMID 95037  0.393
1978 Harris LS, Carchman RA, Martin BR. Evidence for the existence of specific cannabinoid binding sites. Life Sciences. 22: 1131-7. PMID 661500 DOI: 10.1016/0024-3205(78)90082-6  0.49
1978 Martin BR, Montgomery J, Dewey WL, Harris LS. Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 6: 282-7. PMID 26549  0.625
1977 Martin BR, Dewey WL, Harris LS, Beckner JS. 3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses. Research Communications in Chemical Pathology and Pharmacology. 17: 457-70. PMID 897339  0.564
1977 Adams MD, Earnhardt JT, Martin BR, Harris LS, Dewey WL, Razdan RK. A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia. 33: 1204-5. PMID 891878 DOI: 10.1007/Bf01922330  0.634
1977 Martin BR, Dewey WL, Aceto MD, Adams MD, Earnhardt JT, Carney JM. A potent antinociceptive cannabinoid which lacks opiate substitution properties in monkeys. Research Communications in Chemical Pathology and Pharmacology. 16: 187-90. PMID 402685  0.472
1977 Martin BR, Dewey WL, Chau-Pham T, Prnage AJ. Interactions of thyrotropin releasing hormone and morphine sulfate in rodents. Life Sciences. 20: 715-22. PMID 402526 DOI: 10.1016/0024-3205(77)90477-5  0.539
1976 Martin BR, Dewey WL, Harris LS, Beckner JS. 3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. The Journal of Pharmacology and Experimental Therapeutics. 196: 128-44. PMID 1246007  0.575
1976 Wilson RS, May EL, Martin BR, Dewey WL. 9 Nor 9 hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols Journal of Medicinal Chemistry. 19: 1165-1167. PMID 978681 DOI: 10.1002/Chin.197652236  0.538
1975 Martin BR, Dewey WL, Harris LS, Beckner J. Marihuana-like activity of new synthetic tetrahydrocannabinols. Pharmacology, Biochemistry, and Behavior. 3: 849-53. PMID 1208625 DOI: 10.1016/0091-3057(75)90116-1  0.672
Show low-probability matches.